These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function. Duncan GE; Moy SS; Perez A; Eddy DM; Zinzow WM; Lieberman JA; Snouwaert JN; Koller BH Behav Brain Res; 2004 Aug; 153(2):507-19. PubMed ID: 15265649 [TBL] [Abstract][Full Text] [Related]
25. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Klassen AF; Miller A; Fine S Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087 [TBL] [Abstract][Full Text] [Related]
26. A comparison of phenylketonuria with attention deficit hyperactivity disorder: do markedly different aetiologies deliver common phenotypes? Stevenson M; McNaughton N Brain Res Bull; 2013 Oct; 99():63-83. PubMed ID: 24140048 [TBL] [Abstract][Full Text] [Related]
32. Exocytosis regulates trafficking of GABA and glycine heterotransporters in spinal cord glutamatergic synapses: a mechanism for the excessive heterotransporter-induced release of glutamate in experimental amyotrophic lateral sclerosis. Milanese M; Bonifacino T; Fedele E; Rebosio C; Cattaneo L; Benfenati F; Usai C; Bonanno G Neurobiol Dis; 2015 Feb; 74():314-24. PubMed ID: 25497732 [TBL] [Abstract][Full Text] [Related]
33. Alterations in the hippocampal glycinergic system in an animal model of posttraumatic stress disorder. Yamamoto S; Morinobu S; Iwamoto Y; Ueda Y; Takei S; Fujita Y; Yamawaki S J Psychiatr Res; 2010 Nov; 44(15):1069-74. PubMed ID: 20427053 [TBL] [Abstract][Full Text] [Related]
34. Pharmacological characterisation of the GlyT-1 glycine transporter using two novel radioligands. Herdon HJ; Roberts JC; Coulton S; Porter RA Neuropharmacology; 2010 Nov; 59(6):558-65. PubMed ID: 20691713 [TBL] [Abstract][Full Text] [Related]
35. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [TBL] [Abstract][Full Text] [Related]
36. The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Li W; Cui Y; Kushner SA; Brown RA; Jentsch JD; Frankland PW; Cannon TD; Silva AJ Curr Biol; 2005 Nov; 15(21):1961-7. PubMed ID: 16271875 [TBL] [Abstract][Full Text] [Related]
37. The impact of motivation on cognitive performance in an animal model of the negative and cognitive symptoms of schizophrenia. Ward RD; Winiger V; Higa KK; Kahn JB; Kandel ER; Balsam PD; Simpson EH Behav Neurosci; 2015 Jun; 129(3):292-9. PubMed ID: 25914923 [TBL] [Abstract][Full Text] [Related]
38. Impairment of probabilistic reward-based learning in schizophrenia. Weiler JA; Bellebaum C; BrĂ¼ne M; Juckel G; Daum I Neuropsychology; 2009 Sep; 23(5):571-80. PubMed ID: 19702411 [TBL] [Abstract][Full Text] [Related]
39. Anhedonia in schizophrenia: Deficits in both motivation and hedonic capacity. Wang J; Huang J; Yang XH; Lui SS; Cheung EF; Chan RC Schizophr Res; 2015 Oct; 168(1-2):465-74. PubMed ID: 26185892 [TBL] [Abstract][Full Text] [Related]
40. In tribute to Bob Blanchard: Divergent behavioral phenotypes of 16p11.2 deletion mice reared in same-genotype versus mixed-genotype cages. Yang M; Lewis F; Foley G; Crawley JN Physiol Behav; 2015 Jul; 146():16-27. PubMed ID: 26066718 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]